Search clinical trials for: Enalapril plus Losartan

Total 5319 results

German Heart Institute
Charite University, Berlin, Germany; Merck Sharp & Dohme LLC

Unknown

PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

Hypertension

Germany
Children's Hospital Medical Center, Cincinnati
National Institute of Allergy and Infectious Diseases (NIAID); National Institute... and other collaborators

Completed

An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis

United States
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD

Chronic Kidney Disease
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern

Chronic Kidney Disease Patients

China
University of California, San Diego
Massachusetts General Hospital; NYU Langone Health; George Washington University and other collaborators

Completed

A Controlled Trial of Losartan in Posttraumatic Stress Disorder (LOSe-PTSD)

Posttraumatic Stress Disorder

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition

Healthy

India
Novartis Pharmaceuticals

Terminated

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure (PARADIGM-HF)

Heart Failure With Reduced Ejection Fraction

China, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more
St George's, University of London

Terminated

The Renin-Angiotensin System in Essential Hypertension

Hypertension

United Kingdom
Laboratorios Silanes S.A. de C.V.

Completed

Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions

Healthy

Mexico
Hospital General de Niños Pedro de Elizalde

Recruiting

Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

Uric Acid Nephropathy

Argentina
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Losartan

Obesity, Morbid

Norway
University of Oxford

Completed

Losartan and Emotional Memory

Memory | Learning

United Kingdom
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions

Hypertension

United States
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck...

Completed

Angiotensin II Blockade for Chronic Allograft Nephropathy

Proteinuria | Kidney Disease

United States
Tottori University Hospital

Completed

Effects of Losartan on Insulin Resistance in Patients With Heart Failure

Heart Failure
Shanghai Jiao Tong University School of Medicine

Completed

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

Diabetic Nephropathy | Type 2 Diabetes
Anna Stanhewicz, PhD

Recruiting

Losartan for Improved Vascular Endothelial Function After Preeclampsia (LIVE-PE)

Preeclampsia Postpartum

United States
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Hypertension

United States
University of South Florida
National Cancer Institute (NCI)

Withdrawn

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Lung Cancer | Dyspnea | Pulmonary Complications | Radiation Fibrosis
University of Florida
National Institute on Aging (NIA); Abbott

Completed

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study (ENRGISE)

Inflammation

United States
Organon and Co

Completed

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

Hypertension
University of Oxford

Completed

Losartan and Memory

PTSD

United Kingdom
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition

Healthy

India
Assaf-Harofeh Medical Center

Unknown

Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)

Diabetes Mellitus | Atherosclerosis
University of Maryland, Baltimore

Completed

Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition

Bile Salt Export Pump (BSEP) Transporter | Polysorbate 80

United States
Boehringer Ingelheim

Completed

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Hypertension | Diabetic Nephropathies

Taiwan, United States, Canada, Thailand, Korea, Republic of, Argentina, Australia, Brazil, Mexico, New Zealand
University of Oxford

Completed

The Effect of Losartan on Emotional Processing in Healthy Volunteers

Healthy Volunteers
Sanofi

Completed

AVE7688 in Patients With Mild to Moderate Blood Pressure (RAVEL-1)

Hypertension

United States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
Merck Sharp & Dohme LLC

Completed

A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

Hypertension
Ewha Womans University
Chonbuk National University Hospital; Chonnam National University Hospital; Seoul... and other collaborators

Unknown

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1 (BEST-IgAN-1)

Glomerulonephritis, Immunoglobulin A (IgA)
University of Vigo
Novartis; Hospital Clinico Universitario de Santiago

Completed

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Hypertension

Spain
Samsung Medical Center

Recruiting

Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB (REVERSE-AR)

Aortic Valve Insufficiency

Korea, Republic of
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
Qure Healthcare, LLC
Lineagen

Completed

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

Intellectual Disability | Developmental Delay

United States
Organon and Co

Completed

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

High Blood Pressure
Odense University Hospital
University of Southern Denmark; Lundbeck Foundation; Else Poulsen Mindelegat

Unknown

Prevention of Decompensation in Liver Cirrhosis

Ascites | Alcoholic Liver Cirrhosis

Denmark
Massachusetts General Hospital

Recruiting

Losartan in Prevention of Radiation-Induced Heart Failure

Myocardial Fibrosis | Breast Cancer | Radiation-Induced Fibrosis

United States
Armed Forces Post Graduate Medical Institute (AFPGMI)...

Recruiting

Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial

Vascular Access Complication

Pakistan
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
Steadman Philippon Research Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

Osteoarthritis, Knee

United States
University of South Carolina
National Cancer Institute (NCI); American Cancer Society, Inc.

Completed

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

Breast Cancer

United States
Organon and Co

Completed

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Hypertension
Hospital de Clinicas de Porto Alegre
Financiadora de Estudos e Projetos

Completed

Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension (PREVER)

Hypertension | Cardiovascular Disease

Brazil
Hennepin Healthcare Research Institute

Completed

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial (LIFE-HIV)

Fibrosis | Inflammation

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

Hypertension
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Treatment of HYpertension: Morning Versus Evening (THYME)

Essential Hypertension

Netherlands
Organon and Co

Completed

Obese Hypertension Study (0954-315)

Hypertension
Pharmtechnology LLC
Reliance Life Sciences Private Limited

Completed

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Healthy

India
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada

Search clinical trials for: Enalapril plus Losartan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations